SCHEMBL5048035

SCHEMBL5048035

NC(=O)c1c[nH]c2c(=O)[nH]c(=O)[nH]c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.40
PIM3 Q86V86 1/20 0.40
GDA Q9Y2T3 2/20 0.39
ALDH1A1 P00352 3/20 0.37
ATM Q13315 1/20 0.37
GAA P10253 1/20 0.35
ACHE P22303 1/20 0.35
KDM3B Q7LBC6 1/20 0.34
TYMP P19971 1/20 0.34
MEN1 O00255 1/20 0.33
TP53 P04637 1/20 0.33
KMT2A Q03164 1/20 0.33
PDPK1 O15530 1/20 0.33
LMNA P02545 3/20 0.32
MAPT P10636 2/20 0.32
DPYD Q12882 1/20 0.31
ATAD2 Q6PL18 1/20 0.31
CYP19A1 P11511 1/20 0.31
TSHR P16473 1/20 0.31
THPO P40225 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1210894 0.76 GAA (0.50) PIM1PIM3ALDH1A1ATMGAA
Uric Acid SCHEMBL822247 0.67 GDA (0.76) GDAALDH1A1GAAACHETYMP
SCHEMBL3243045 0.66 PIM3 (0.59) PIM1PIM3ALDH1A1ATMMEN1
SCHEMBL1210851 0.65 KDM3B (0.69) PIM1PIM3ALDH1A1ATMGAA
Uric Acid SCHEMBL8330954 0.64 GDA (0.70) GDAALDH1A1GAAACHETYMP
SCHEMBL5045201 0.64 DPYD (0.60) GDAALDH1A1GAAACHEDPYD
SCHEMBL9008314 0.64 GDA (0.71) GDAALDH1A1GAAACHETYMP
SCHEMBL30853320 0.63 BTK (0.45) PIM1PIM3ALDH1A1ATMPDPK1
SCHEMBL6766607 0.63 PDPK1 (0.51) PIM1PIM3ALDH1A1ATMPDPK1
SCHEMBL16703602 0.63 GAA (0.48) ALDH1A1GAAKDM3BLMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966215-A1 CONDENSED HETEROCYCLIC COMPOUNDS USEFUL AS DPP-IV INHIBITORS Novartis AG (CH) 2008-09-10 EP disclosed
WO-2007071738-A1 CONDENSED HETEROCYCLIC COMPOUNDS USEFUL AS DPP-IV INHIBITORS NOVARTIS AG (CH) 2007-06-28 WO disclosed